ǰÑÔ
θÑ×(gastritis)ÊÇÖ¸±¬·¢ÔÚθð¤Ä¤²ã£¨ÉÏÆ¤Ï¸°û¡¢¹ÌÓв㡢ð¤Ä¤¼¡£©µÄÑ×Ö¢¡£°´ÁÙ´²·¢²¡µÄ»º¼±ºÍ²¡³ÌµÄÊÇ·Ç£¬·ÖΪ¼±ÐÔθÑ׺ÍÂýÐÔθÑס£¼±ÐÔθÑ×µÄ×éÖ¯²¡ÀíÑ§ÌØÕ÷ÊÇθð¤Ä¤¹ÌÓвãÒÔÖÐÐÔÁ£Ï¸°ûΪÖ÷µÄÑ×ÐÔϸ°û½þÈóÒÔ¼°ÁíÒ»ÀàÒÔÃÓÀóöÑªÎªÌØÕ÷µÄ¼±ÐÔθð¤Ä¤²¡±ä¡£ÂýÐÔθÑ×ÊÇ Î¸ð¤Ä¤ËðÉËÓëÐÞ¸´Í¬Ê±±£´æµÄÒ»ÖÖ½»ÌæÀú³Ì£¬°´×éÖ¯²¡Àíѧ¸Ä±ä£¬ÓÖ·ÖΪÂýÐÔdz±íÐÍθÑ׺ÍÂýÐÔήËõÐÍθÑ×£¬Ç°ÕßÒÔð¤Ä¤²ãÁܰÍϸ°ûºÍ½¬Ï¸°û½þÈóΪÖ÷£¬ºóÕßÒÔÑ×ÐÔϸ°û½þÈóºÍ¹ÌÓвãÏÙÌåïÔÌ£¨Î®Ëõ£©²¢°éÓÐϸ°ûÔöÉúÎªÌØÕ÷¡£Î¸Ñ××îÖ÷ÒªµÄ²¡ÒòÊÇÓÄÃÅÂݸ˾ú(helicobacter pylori, Hp)ѬȾ£¬ÆäËû²¡ÒòÉÐÓзÇçÞÌåÀ࿹Ñ×Ò©(non-steroidal anti inflammatory drugs,NSAIDs)µÄʹÓá¢Ê®¶þÖ¸³¦Òº·´Á÷¡¢ÒûʳÒòËØ£¨Èç¸ßΡ¢¸ßÑΡ¢ÒÒ´¼¡¢´Ì¼¤ÐÔʳÎÒÔ¼°Ó¦¼¤µÈ¡£
ÔÚ¶¯ÎïÄ£×ÓµÄÖÆ±¸ÉÏ£¬¼±ÐÔθÑ×Ò»Ñùƽ³£ÊýÌì»òÊýÖÜÄÚ·ºÆð£¬ÊýÖָܻ´»òǨÑÓÖÁÂýÐÔθÑ×£»ÂýÐÔθÑ×ÔìÄ£Ðèʱ½Ï³¤£¨Ê®¼¸ÖÜÖÁ¼¸Ê®ÖÜ£©£¬ÓÐʱÔÚÂýÐÔθÑ×»ù´¡ÉÏ·ºÆðÔ˶¯ÆÚ£¨¼±ÐÔÆÚ£©ÌåÏÖ£¬Ñ×Ö¢Ò»Á¬±£´æ£¬Ó㦻¯ÉúµÈ°©Ç°²¡±äΣº¦¡£
2005Ä꣬ŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÅäºÏÊÚÓèÁ˰ĴóÀûÑÇ¿ÆÑ§¼ÒWarrenºÍMarshall£¬±íÑïËûÃǶԓÓÄÃÅÂݸ˾úÒÔ¼°ËüÔÚθÑ׺ÍÏû»¯ÐÔÀ£Ññ²¡ÖеÄ×÷ÓÔÑо¿µÄÓÅÒìТ˳¡£HpÊÇÒýÆðθÑ×µÄÖ÷Òª²¡Ô¾ú¡£µ«ÔÚ1984ÄêÒÔǰ£¬Î§ÈÆ×ÅHp¾¿¾¹ÊÇθÑ×µÄÔµ¹ÊÔÓÉ¡¢ÕÕ¾ÉθÑ×µÄЧ¹û£¨»òÅãͬÎ£¬Ñ§Êõ½ç³Ö²î±ð¿´·¨ÇÒÖ÷ÒªÇãÏòÊÇÒÔΪθÑ×»¼ÕßθÄÚ·¢Ã÷µÄHpÊÇÖÆ×÷±ê±¾Àú³ÌÖб»ÎÛȾµÄЧ¹û¡£MarshallÒÔ×ÔÉí¿Ú·þHpÓÕ·¢Á˼±ÐÔθÑס¢¿¹HpÖÎÁƺóθÑ×ȬÓúµÄÊÔÑéЧ¹û£¬Ã÷È·µØ»Ø¸²ÁË´ËÎÊÌâ¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
µ±HpѬȾÒýÆðµÄ¼±ÐÔθÑ×δ»ñµÃʵʱÓÐÓõÄÖÎÁƶøµ¼ÖÂHpÔÚθÄÚÒ»Á¬±£´æ£¬»òHpÒÔС¼ÁÁ¿¡¢³¤Ê±¼äµÄ·½·¨Ñ¬È¾»úÌåµÈ£¬¶¼¿Éµ¼ÖÂθð¤Ä¤µÄÂýÐÔÑ×Ö¢¡£ÂýÐÔÑ×֢ʹθð¤Ä¤Öظ´Êܵ½Ë𺦡¢ð¤Ä¤ÏÙÌåÊýÄ¿ïÔÌÉõÖÁÏûÊż´·ºÆðήËõ¸Ä±ä£¬¿É°éÓг¦ÉÏÆ¤»¯Éú¡£ÔÚHp±»·¢Ã÷֮ǰ£¬ÂýÐÔήËõÐÍθÑ×Ö÷ÒªÔµ¹ÊÔÓɹé×ïÓÚµ¨Ö·´Á÷Èë裬´Ë»¼ÕßθÄÚpHÒ»Ñùƽ³£½Ï¸ß£¨¼´µÍËá״̬£©¡£HpµÄ·¢Ã÷£¬ÐÞÕýºÍÔö²¹ÁË´ËÐÍθÑ׵ķ¢²¡»úÖÆ¡£ÓÉÓÚHpÆÊÎöÄòËØ±¬·¢µÄ̼ËáÇâ¸ùÀë×Ó¿ÉÒÔÖкÍθËᣬʹθÄÚpHÉý¸ß¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
HpѬȾÃɹÅɳÊóµÄÂýÐÔdz±íÐÍθÑ×Ä£×Ó£ºÃɹÅɳÊ󣬴ÆÐÔ£¬8ÖÜ£¬55~60g¡£¹àθǰ24Сʱ½ûʳ½ûË®¡£Hp¾úÖêÊÇ´ÓÁÙ´²Ê®¶þÖ¸³¦À£Ññ»¼ÕßÌåÄÚÊèÉ¢µÄLWLM98003£¬Å¨¶ÈΪ108CFU/ml¡£Ã¿Ö»Êó¹àθ0.5ml£¬ÉÏ¡¢ÏÂÖç¸÷Ò»´Î£¬¸ôÌìÉÏÎçÔÙ¹àÒ»´Î£¬¹àθºó2Сʱ»Ö¸´ÒûʳÒûË®¡£Ä©´Î¹àθºóµÚ12¡¢20¡¢24ÖÜ»®·ÖÕý·¨¶¯Îȡθ×éÖ¯¡£µÚ12ÖÜÈâÑۿɼûθñ¼¼°ÓÄÃÅð¤Ä¤³öѪ£¬¾µÏ¼ûð¤Ä¤²ãºÍð¤Ä¤Ï²ã´ó×ÚÁܰÍÂËÅݺ͵¥ºËϸ°û½þÈó¡£
HpѬȾСÊóµÄÂýÐÔήËõÐÍθÑ×Ä£×Ó£ºÀ¥Ã÷СÊó£¬ÐÛÐÔ£¬3ÖÜ£¬16~18g£¬¹àθǰ24Сʱ½ûʳ¡¢Ç°4Сʱ½ûË®£¬Ã¿Ö»Ð¡Êó¹àHp¾úÒº200µ1(5× 108CFU/ml)£¬ÌìÌìÒ»´Î£¬Ã¿´Î¾àÀë2Ì죬¹²¹àθ3´Î¡£¹àθºó¼ÌÐø½ûʳˮ4Сʱ¡£Ä©´Î¹àθºó8ÖÜÕý·¨Ð¡Ê󡣿ɼûHpÖ÷Òª¶¨Ö²ÓÚêÚÃÅ¡¢Î¸ÌåºÍÓÄÃÅð¤Ä¤ÉÏÆ¤µÄð¤Òº²ã£¬×éÖ¯²¡Àí¿É¼ûθð¤Ä¤ÉÏÆ¤³äѪ¡¢»µËÀ¡¢ÍÑÂ䣬¹ÌÓвãºÍð¤Ä¤Ï²ãÏÔ×ŵÄÑ×֢ϸ°û½þÈó£¬ÒÔÁܰÍϸ°ûΪÖ÷£¬Æä´ÎÊÇÖÐÐÔÁ£Ï¸°ûºÍÉÙÁ¿ÊÈËáÐÔÁ£Ï¸°û£¬ÏÙÉÏÆ¤×é֯ήËõ¡¢ÏÙÌå½á¹¹ÆÆËð¡£
¡¾Ä£×ÓÌØµã¡¿£º
HpѬȾÒýÆðµÄÂýÐÔθÑ×£¬·ÖΪdz±íÐͺÍήËõÐÍ¡£Á½ÕßµÄÖ÷񻂿±ðÊÇÓÐÎÞÏÙÌ寯ËðºÍÊýÄ¿ïÔÌ£¨¼´ð¤Ä¤Î®Ëõ£©¡£µ±ÂýÐÔθÑ×·ºÆðÔ˶¯ÆÚ¸Ä±äʱ£¬¿É¼ûµ½ÖÐÐÔÁ£Ï¸°û½þÈóÓëÁܰ͵¥ºËϸ°û½þÈ󲢴棬´ËʱHpÒøÈ¾ÑôÐÔÂʿɴï90£¥ÒÔÉÏ£¬ÖÐÐÔÁ£Ï¸°û½þÈó¿É´ï90£¥ÒÔÉÏ¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
´ËÄ£×Ó¿ÉÓÃÓÚÊÓ²ìHpѬȾµÄ²¡ÀíÀú³Ì¼°ÖÖÖÖ¿¹HpѬȾҩÎïµÄÁÆÐ§ÊӲ죬¹ØÓÚÑо¿HpѬȾ¡¢ÂýÐÔθÑס¢Ïû»¯ÐÔÀ£ÑñÒÔ¼°Î¸°©µÈµÄ¹ØÏµ¼°Æä·¢²¡»úÖÆ¶¼ÓÐÖ÷ÒªÒâÒå¡£
²Î¿¼ÎÄÏ×£º
1.ÎĹúÈÝ£¬ÓàÀö÷£¬µË½£¬µÈ£®³ÂÏã¶°×¶½ºÄÒ¶ÔʵÑéÐÔ¼±ÐÔθÑ×µÄ×÷ÓÃ. ¹óÖÝÒ½Ò©£¬2003,27 (3): 203-204
2.ÁõÀÚ£¬ÀîÇÙ»ª£¬ÅËÖ¾»ª£¬µÈ£®ÁªÕýµ±Ö´óÊóÂýÐÔήËõÐÔθÑ×Ä£×ӵĽ¨É裮ÖйúÈ«¿ÆÒ½Ñ§£¬2010, 13(11C):3769- 3771
3.榽¡Ãô£¬Îâ¼Ó¹ú£¬²ÜÙ»£¬µÈ£®ÊóÂýÐÔήËõÐÔθÑ×Ä£× ½¨Éè¼°ÖÂήËõÒòËØÌ½ÌÖ£®ÖлªÏû»¯ÔÓÖ¾£¬2001,21 (2):75-78
4.ÕÅÈٹ⣬¶Î¹ã²Å£¬·¶ÇåÌ㬵ȣ®ÓÄÃÅÂݸ˾úѬȾµÄÀ¥Ã÷СÊóÄ£×ӵĽ¨Éè. ÖлªÒ½Ñ§ÔÓÖ¾£¬2006,86 (12):857-859
5.ÕÅÃô£¬ÀîÇ¿£¬¿×¹Åæ«£®Èý¾Åθ̩¿ÅÁ£ÖÎÁÆÊµÑéÐÔ´óÊó¼±ÐÔθÑ×µÄÒ©ÀíÑо¿£®ÏÖ´úÏû»¯¼°½éÈëÕïÁÆÔÓÖ¾£¬2000, 5(4):28-32
6.ÕÅάɣ¬ÕÅÓÀºê£¬Ðí´ºÐÓ£¬µÈ£®C57BL/6СÊóÓÄÃÅÂݸ˾úѬȾθÑ×Ä£×ӵĸ´ÖÆ£®¹óÖÝÒ½Ò©£¬2013, 37 (2): 105-109
7.¹ù¸Õ£¬ÍõÒ㳬£¬×ÞÈ«Ã÷£¬µÈ£®ÓÄÃÅÂݸ˾úºã¾ÃѬȾÃɹÅɳÊóÄ£×ӵĽ¨É裮ÖлªÎ¢ÉúÎïѧºÍÃâÒßѧÔÓÖ¾£¬2001, 21 (6):683-684
8.÷ÁÖ. 賦²¡Ñ§Ñо¿µÄÒ»´ÎÍ»ÆÆÒ»2005Äêŵ±´¶ûÐÄÀíѧ»òҽѧ½±ÏÈÈÝ£®ÐÄÀí¿ÆÑ§Ï£Íû£¬2006,37(2):187-192
9.Goodwin CS, Armstrong JA, Marshall BJ. Campylobacte.r pyloridis, gastritis, and peptic ulceration. J Clin Pathol, 1986, 39 (4):353-365
10. Kayabali M, Hazar H, Gi.irsoy MA, et al. Free oxygen radicals in restraint -induced stress gastritis in the rat.Surg Today, 1994, 24 (6):530-533